oa Urothelial carcinoma of the fossa navicularis successfully treated with laser ablation and distal urethrectomy: A case report

References

1. Gatta G, van der Zwan JM, Casali PG, Siesling S, Dei Tos AP, Kunkler I, et al. Rare cancers are not so rare: the rare cancer burden in Europe. Eur J Cancer. 2011 Nov; 47:(17):2493–511.
   [Google Scholar]
2. Steele GS, Fielding JR, Renshaw A, Loughlin KR. Transitional cell carcinoma of the fossa navicularis. Urology. 1997 Nov; 50:(5):792–5.
   [Google Scholar]
3. Dalbagni G, Zhang ZF, Lacombe L, Herr HW. Male urethral carcinoma: analysis of treatment outcome. Urology. 1999 Jun 1; 53:(6):1126–32.
   [Google Scholar]
4. Li N, Yang L, Zhang Y, Zhao P, Zheng T, Dai M. Human papillomavirus infection and bladder cancer risk: a meta-analysis. J Infect Dis. 2011 Jul 15; 204:(2):217–23.
   [Google Scholar]
5. Ono Y, Matsumoto K, Kosaku N, Nakazato H, Yamanaka H. Transitional cell carcinoma in the fossa navicularis of the male urethra: a case report. Int J Urol. 1998 May; 5:(3):294–5.
   [Google Scholar]
6. Cohen RJ, Garrett K, Golding JL, Thomas RB, McNeal JE. Epithelial differentiation of the lower urinary tract with recognition of the minor prostatic glands. Hum Pathol. 2002 Sep 1; 33:(9):905–9.
   [Google Scholar]
7. Resnick MJ, Wein AJ. Transitional cell carcinoma of the fossa navicularis in a man with preexisting adenocarcinoma of the prostate. Urol Int. 2006; 76:(2):186–8.
   [Google Scholar]